The World Health Organization issued an alert on falsified versions of Ozempic, the popular drug used to treat type 2 diabetes and obesity. The WHO warned health care professionals and the public to be aware of the counterfeits, which it said are increasing as demand for the drugs grows. NBC News' Anne Thompson reports.
Tirzepatide, the active ingredient in Eli Lilly’s Mounjaro and Zepbound, leads to more weight loss than semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, new research suggests. The study, published Monday in JAMA Internal Medicine, is thought to be the first head-to-head comparison of the two blockbuster weight loss drugs. Since Zepbound was approved for weight loss in late 2023, it appeared to have an advantage over Wegovy.
Researchers will still need to do a randomized, controlled clinical trial to see which medication truly comes out on top. Last year, Lilly began a phase 3 trial of 700 patients comparing the two medications. The trial is expected to be completed in November, according to ClinicalTrials.gov.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Zepbound Sheds More Weight Than Wegovy, Study FindsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Added Health Benefits Of Wegovy, Zepbound Could Attract More Men, Doctors SayEvidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart disease risk, treat sleep apnea and address other health issues may help...
Read more »
Senate panel to weigh Novo Nordisk subpoena on Ozempic, Wegovy pricesThe U.S. Senate health panel said on Tuesday it would vote this month on whether to subpoena Novo Nordisk to answer questions about U.S. prices for weight loss drugs Ozempic and Wegovy, which are far higher than those in other countries.
Read more »
Weight Loss Drugs Like Wegovy and Ozempic May Influence How Food Tastes, Study FindsIn 'An Oprah Special: Shame, Blame and the Weight Loss Revolution,' Oprah talks obesity and weight loss drugs.
Read more »
Potential link between Ozempic, Wegovy and serious eye condition revealed in new studyPlastic surgeons warn of 'Ozempic face' crisis in Hollywood
Read more »
Ozempic and Wegovy Linked to Rare Blindness Risk, Study FindsNew research has found a potential link between semaglutide use and a rare eye condition called NAION, though more work is needed to prove causation.
Read more »